Evidence map›Paper›PMID 41843250›Full record

ArticleEJNMMI physics2026

Smart scanning for two: [

Ilja S Deurloo, Milou M Steemers-de Boer, Johannes H van Snick, Klaas Pieter Koopmans, Riemer H J A Slart, Walter Noordzij, Adrienne H Brouwers, Gilles N Stormezand, Ton Velleman, Erik H J G Aarntzen and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ilja S DeurlooDepartment of Medical Physics, Isala, Zwolle, The Netherlands.ORCID http://orcid.org/0009-0002-0035-3407
Milou M Steemers-de BoerDepartment of Nuclear Medicine, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.ORCID http://orcid.org/0009-0004-9233-6616
Johannes H van SnickDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands.ORCID http://orcid.org/0009-0008-0417-1823
Klaas Pieter KoopmansDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands.ORCID http://orcid.org/0009-0004-9359-297X
Riemer H J A SlartDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands.ORCID http://orcid.org/0000-0002-5565-1164
Walter NoordzijDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands.ORCID http://orcid.org/0000-0001-6386-5499
Adrienne H BrouwersDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands.ORCID http://orcid.org/0000-0003-2698-1516
Gilles N StormezandDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands.ORCID http://orcid.org/0000-0002-1370-8791
Ton VellemanDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands.ORCID http://orcid.org/0000-0002-5731-7258
Erik H J G AarntzenDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands.ORCID http://orcid.org/0000-0002-3809-0182
Berlinda J de Wit-van der VeenDepartment of Nuclear Medicine, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-7860-2904
Wouter V VogelDepartment of Nuclear Medicine, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-4992-8024
Sanne M JansenDepartment of Nuclear Medicine, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-6749-3220
Arthur J A T BraatDepartment of Nuclear Medicine, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-8824-8697
Andor W J M GlaudemansDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands.ORCID http://orcid.org/0000-0001-8081-0641
Oleksandra V IvashchenkoDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands. o.v.ivashchenko@umcg.nl.ORCID http://orcid.org/0000-0001-8675-8987

Funding

Siemens Healthineers Siemens HealthineersUniversitair Medisch Centrum Groningen Universitair Medisch Centrum Groningen
6 · The paper itself

Abstract

purposeThis study aimed to evaluate the image quality-dose trade-off in pregnant patients imaged with long-axial field-of-view [

methodsPatients imaged with [

resultsEleven patients were included in image quality analysis and dosage model optimization. SNR strongly correlated with Likert scores (R² = 0.80), with 10.72 SNR indicating acceptable image quality. BSA best predicted image quality (R² = 0.85), outperforming weight (R² = 0.78), weight-to-height ratio (R² = 0.63), and body mass index (R² = 0.38). The proposed dosage model reduces activity by 41-96% compared to current local pregnancy and adult protocols, resulting in estimated foetal radiation doses of 0.066 mGy (PET) and 0.31 mGy (CT).

conclusionBSA accurately predicted [

Indexed as

[18F]FDGDose optimizationFoetal doseLAFOV PET/CTPregnancy

Identifiers

PMID41843250
PMCPMC13106102

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.